Skip to main content
. 2024 Jun 17;12(7):646–658. doi: 10.14218/JCTH.2024.00089

Fig. 2. Sustained virologic response at week 12 after end-of-treatment (SVR12) rates for patients with chronic hepatitis C virus stratified by genotypes (GTs), liver fibrosis stage, and prior treatment.

Fig. 2

CH, Chronic hepatitis; LC, Liver cirrhosis; TE, Treatment-experienced; TN, Treatment-naive; CI, Confidence interval.